Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.12 USD -0.88% Intraday chart for NKGen Biotech, Inc. -11.11% -86.51%
Apr. 29 Nkgen Biotech Announces FDA Clearance of Investigational New Drug Application for SNK01 NK Cell Therapy in Parkinson's Disease CI
Apr. 29 NKGen Biotech, Inc. announced that it has received $0.55 million in funding from FirstFire Capital Management LLC, Meteora Capital, LLC, Glazer Capital, LLC, Meteora Strategic Capital, LLC, Sandia Investment Managment LP CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. News NKGen Biotech, Inc.
  6. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW